Pacer Advisors, Inc. Organon & Co. Transaction History

Pacer Advisors, Inc.

$39 Billion
Q2 2024

A detailed history of Pacer Advisors, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 350 shares of OGN stock, worth $6,391. This represents 0.0% of its overall portfolio holdings.

Number of Shares

350

Previous 302 15.89%

Holding current value

$6,391

Previous $5,000 40.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.45 - $21.96 $837 - $1,054	48 Added 15.89%	350 $7,000
Q4 2023 Jan 16, 2024	SELL	$10.95 - $17.32 $536,298 - $848,281	-48,977 Reduced 99.39%	302 $4,000
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $147,584 - $211,457	8,896 Added 22.03%	49,279 $855,000
Q2 2023 Jul 12, 2023	BUY	$19.27 - $24.63 $472,558 - $604,001	24,523 Added 154.62%	40,383 $840,000
Q1 2023 May 02, 2023	BUY	$21.42 - $32.08 $313,010 - $468,785	14,613 Added 1171.85%	15,860 $373,000
Q4 2022 Feb 06, 2023	SELL	$23.31 - $28.61 $714,078 - $876,438	-30,634 Reduced 96.09%	1,247 $34,000
Q3 2022 Oct 18, 2022	SELL	$23.4 - $34.25 $33 Million - $48.3 Million	-1,410,577 Reduced 97.79%	31,881 $746,000
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $10.7 Million - $13.1 Million	336,543 Added 30.43%	1,442,458 $48.7 Million
Q1 2022 Apr 05, 2022	BUY	$30.45 - $39.36 $18.5 Million - $24 Million	609,062 Added 122.58%	1,105,915 $38.6 Million
Q4 2021 Feb 03, 2022	BUY	$28.67 - $37.13 $5.69 Million - $7.37 Million	198,413 Added 66.48%	496,853 $15.1 Million
Q3 2021 Oct 15, 2021	BUY	$28.63 - $35.64 $7.58 Million - $9.43 Million	264,653 Added 783.3%	298,440 $9.79 Million
Q2 2021 Jul 21, 2021	BUY	$28.45 - $38.0 $961,240 - $1.28 Million	33,787 New	33,787 $1.02 Million

Others Institutions Holding OGN

# of Institutions

795

Shares Held

191M

Call Options Held

1.59M

Put Options Held

931K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.64B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Organon & Co. Transaction History